Antifungal dosing and therapeutic drug monitoring Author: A Ullmann Download slideshow Slide presentations Select Conference nameAdvances Against Aspergillosis & Mucormycosis (AAAM 9th), Lugano, Switzerland 2020Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, GreeceAdvances against Aspergillosis 3rd Miami USA. January 16-19 2008Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012Advances Against Aspergillosis 8th (AAA) January 2018 Lisbon, PortugalAdvances Against Aspergillosis and Mucormycosis meeting 2024Advances Against Aspergillosis, 1st (AAA) September 2004, San FranciscoAdvances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentationsAdvances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slidesAnglo-Celtic debate, Dublin 2005, sponsored by PfizerAnnual Meeting of the Infectious Diseases Society of America 47th (IDSA) Oct 29th-Nov 1st 2009Antifungal Drug Development SummitAspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007Aspergillus workshop at the 7th European Conference of Fungal Genetics, Copenhagen, April 2004 (ECFG)Belgian Society for Mycology/ SBIMC Nov 8th, 2012British Mycological Society, 6-8 April 2009 (BMS)British Mycological Society, Annual Scientific Meeting 2005. EXPLOITATION OF FUNGI , University of Manchester: September 5-8 2005 (BMS)British Society for Allergy & Clinical Immunology June 29th - 1st July (BSACI)ECCMID 16th (2006) Nice, FranceECCMID 18th (2008) Barcelona, Spain.ECCMID 20th (2010) Vienna, AustriaECCMID 21st / 27th ICC (2011) Milan, ItalyECCMID 22nd (2012), London, UKECCMID 23rd (2013), Berlin, GermanyECCMID 24th (2014), Barcelona, SpainECCMID 25th (2015) Copenhagen DenmarkECCMID 27th (2017) Vienna , AustriaEuropean Respiratory Society (ERS) Advances in the understanding of Aspergillosis 18th-22nd September, 2010Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)GeneralHS TalksICAAC 2006 Sept 27-30, San FranciscoICAAC 2014, Washington Sep 5-9ICAAC 47th Chicago September 17-20th 2007ICAAC 50th Boston 12th-15th September, 2010ICAAC, 53rd, Denver September 10-13 2013Indoor Air 2015Infocus 2014Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009International Collaborative Mycology Conference (1st Karachi)International Collaborative Mycology Conference 1st 2017International Union of Microbiological Societies 2011( IUMS) Mycology 6-10th SeptISHAM 2006 June 25-29, Paris 2006ISHAM 2015ISHAM 2022ISHAM 20th (2018) Amsterdam, NetherlandsISHAM Asia 2021ISHAM Tokyo May 25-29 2009New York Academy of Sciences: Invasive aspergillosis - New approaches against a dangerous fungal infectionSecond Research Coordination Meeting of IAEA CRP:Behaviour of Cementitious Materials in Long Term Storage and Disposal of Radioactive WasteSociety for Indian Human & Animal Mycologists 12th (SIHAM) Bengalaru 2018Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012TIMM 8th 2017Trends in Medical Mycology 2nd, Berlin, October 2005 (TIMM)Trends In Medical Mycology 3rd (TIMM)Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM) Showing 10 posts of 557 posts found. Title Author Year In-vitro activity of F901318 and comparators against clinical isolates of cryptic species of Aspergillus Ana Alastruey-Izquierdo 2017 Resistance mechanisms to antifungals David Perlin 2017 A prospective, phase 2, multicentre, open-label, randomized, comparative study to estimate the safety, tolerability, pharmacokinetics, and efficacy of oral SCY-078 vsstandard-of-care following initial intravenous echinocandin therapy in the treatment of.. Peter G. Pappas 2017 Year in infectious disease – Top ten papers Bart Jan Kullberg 2017 Retrospective observational cohort study comparing the management and outcome of culture-positive invasive aspergillosis due to Aspergillus fumigatus with wildtype and non-wildtype triazole susceptibility Bram Lestrade 2017 Prevalence and characterization of azole-resistant Aspergillus fumigatus in German CF-patients Raphael Seufert 2017 Comparison of two molecular assays concerning detection and characterization of Aspergillus fumigatus azole resistance and cyp51A mutations in clinical isolates and primary clinical samples of immunocompromised patients Birgit Spiess 2017 Unveiling the mechanistic basis underlying Aspergillus fumigatus 5-flucytosine resistance Fabio Gsaller 2017 Invasive fungal disease in paediatric patients undergoing therapy for a haematological malignancy or receiving allogeneic haematopoietic stem-cell transplantation: an interim analysis of the prospective multicentre study IFI-PED Thomas Lehrnbecher 2017 Aspergillus infection in patients supported on extracorporeal membrane oxygenation (ECMO). Isabel Rodriguez Goncer 2017 Previous1...78910111213141516171819202122232425...56Next
